EMEA-000116-PIP01-07-M09
Key facts
Invented name |
Trobalt
|
Active substance |
retigabine
|
Therapeutic area |
Neurology
|
Decision number |
P/0299/2018
|
PIP number |
EMEA-000116-PIP01-07-M09
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
|
Contact for public enquiries |
Glaxo Group Limited
E-mail: eu.paediatric-plans@gsk.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|